References in periodicals archive ?
Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has presented data from a Phase II clinical study (Study 201) on its in-house-developed investigational dual orexin receptor antagonist (DORA) E2006 in patients with insomnia disorder at the 53rd American College of Neuropsychopharmacology (ACNP) Annual Meeting held from December 7 through 11, 2014, in Phoenix, Arizona in the United States.
This three-year multi-method study, published today in European Neuropsychopharmacology, covers 30 countries (the European Union plus Switzerland, Iceland and Norway) and a population of 514 million people.
The progressive rise seen in the journals Neuropsychopharmacology and Journal of Psychopharmacology stands out.
Progress in NeuroPsychopharmacology and Biological Psychiatry, 25, 141-166.
Details of these findings will be soon available in the International Journal of Neuropsychopharmacology.
Presenting their results to the American College of Neuropsychopharmacology, the New York State Psychiatric Institute researchers, said their results were similar to tests measuring reduction in brain volumes on MRI scans and memory tests.
The researchers, presenting their results at the American College of Neuropsychopharmacology annual meeting, said their odour identification test was a strong predictor of Alzheimer's.
Studies show that the vitamin promotes sleep, especially in people with sleep disorders (Sleep 1990; 13 (1):15-23; Neuropsychopharmacology 1996; 15(5):456-464).
After three months, their brains were examined and both sets of rats had lost a neurotransmitter called 5-hydroxytryptamine, according to a report in the journal Neuropsychopharmacology.
Presented at the 15th Congress of the European College of Neuropsychopharmacology, 2002 (poster)
The European College of Neuropsychopharmacology, the European Federation of Neurological Societies, and the Federation of European Neuroscience Societies say the last-minute amendments will severely hamper progress in the understanding of these diseases.
The Institute for Scientific Information (ISI) has announced that it has signed an agreement with the American College of Neuropsychopharmacology (ACNP) whereby members of the ACNP will take an active role as editorial advisors to ISI's Focus On: Psychopharmacology database.